Advertisement
Advertisement
NMTC
NeuroOne Medical Technologies Corporation Common Stock
4.76
USDSponsored
+0.22
+4.85%
May 08, 15:58 UTC -4
Closed
After-Market
4.72
-0.04
-0.84%
NMTC Earnings Reports
Positive Surprise Ratio
NMTC beat 14 of 17 last estimates.
82%
Next Report
In 2 Days
Date of Next Report
May 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.63M
/-$0.23
Implied change from Q1 26 (Revenue/ EPS)
-9.15%
/+27.78%
Implied change from Q2 25 (Revenue/ EPS)
+89.05%
/+228.57%
NeuroOne Medical Technologies Corporation Common Stock earnings per share and revenue
On Feb 17, 2026, NMTC reported earnings of -0.18 USD per share (EPS) for Q1 26, beating the estimate of -0.24 USD, resulting in a 26.47% surprise. Revenue reached 2.89 million, compared to an expected 2.73 million, with a 5.90% difference. The market reacted with a -16.50% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.23 USD, with revenue projected to reach 2.63 million USD, implying an increase of 27.78% EPS, and decrease of -9.15% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
FAQ
What were NeuroOne Medical Technologies Corporation Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, NeuroOne Medical Technologies Corporation Common Stock reported EPS of -$0.18, beating estimates by 26.47%, and revenue of $2.89M, 5.9% above expectations.
How did the market react to NeuroOne Medical Technologies Corporation Common Stock's Q1 2026 earnings?
The stock price moved down -16.5%, changed from $0.81 before the earnings release to $0.68 the day after.
When is NeuroOne Medical Technologies Corporation Common Stock expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for NeuroOne Medical Technologies Corporation Common Stock's next earnings report?
Based on 4
analysts, NeuroOne Medical Technologies Corporation Common Stock is expected to report EPS of -$0.23 and revenue of $2.63M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement